Why is Thyrocare Technologies Ltd ?
1
High Management Efficiency with a high ROE of 23.66%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 12.02% and Operating profit at 9.20% over the last 5 years
4
With a growth in Net Profit of 45.32%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 8 consecutive quarters
- PAT(Latest six months) At Rs 81.88 cr has Grown at 78.86%
- NET SALES(Latest six months) At Rs 412.06 cr has Grown at 20.04%
- ROCE(HY) Highest at 34.15%
5
With ROE of 23.9, it has a Expensive valuation with a 10.6 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 45.44%, its profits have risen by 62.4% ; the PEG ratio of the company is 0.6
6
100% of Promoter Shares are Pledged
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
- The proportion of pledged holdings has increased by 14.16% over the last quarter
How much should you hold?
- Overall Portfolio exposure to Thyrocare Tech. should be less than 10%
- Overall Portfolio exposure to Healthcare Services should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Thyrocare Tech. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Thyrocare Tech.
45.44%
1.06
42.67%
Sensex
-2.38%
-0.19
12.70%
Quality key factors
Factor
Value
Sales Growth (5y)
12.02%
EBIT Growth (5y)
9.20%
EBIT to Interest (avg)
63.41
Debt to EBITDA (avg)
0.17
Net Debt to Equity (avg)
-0.31
Sales to Capital Employed (avg)
1.10
Tax Ratio
30.63%
Dividend Payout Ratio
0
Pledged Shares
100.00%
Institutional Holding
25.46%
ROCE (avg)
32.53%
ROE (avg)
23.66%
Valuation Key Factors 
Factor
Value
P/E Ratio
40
Industry P/E
55
Price to Book Value
10.57
EV to EBIT
29.39
EV to EBITDA
22.38
EV to Capital Employed
14.94
EV to Sales
6.91
PEG Ratio
0.62
Dividend Yield
2.63%
ROCE (Latest)
47.70%
ROE (Latest)
23.91%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Movement
20What is working for the Company
PAT(Latest six months)
At Rs 81.88 cr has Grown at 78.86%
NET SALES(Latest six months)
At Rs 412.06 cr has Grown at 20.04%
ROCE(HY)
Highest at 34.15%
PBT LESS OI(Q)
At Rs 36.57 cr has Grown at 52.95%
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Thyrocare Tech.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 36.57 cr has Grown at 52.95%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 33.89 cr has Grown at 77.4%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Latest six months
At Rs 412.06 cr has Grown at 20.04%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Thyrocare Tech.
Non Operating Income - Quarterly
Highest at Rs 4.98 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income






